BofA Securities Upgrades Ultragenyx Pharma (RARE) to Buy; Sees Room for Pipeline Upside
Tweet Send to a Friend
(Updated - June 29, 2021 6:53 AM EDT)BofA Securities analyst Tazeen Ahmad upgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
